Steven Gilman - Jun 7, 2021 Form 4 Insider Report for Akebia Therapeutics, Inc. (AKBA)

Role
Director
Signature
/s/ Nicole R. Hadas, attorney-in-fact for Steven C. Gilman
Stock symbol
AKBA
Transactions as of
Jun 7, 2021
Transactions value $
-$15,163
Form type
4
Date filed
6/9/2021, 04:26 PM
Previous filing
Jun 3, 2021
Next filing
Jun 21, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AKBA Common Stock Sale -$15.2K -4.57K -8.69% $3.32 48K Jun 7, 2021 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This sale was made pursuant to a 10b5-1 trading plan to cover tax withholding obligations in connection with the vesting and settlement of 100% of the Reporting Person's restricted stock units granted on June 5, 2020.
F2 This transaction was executed in multiple trades at prices ranging from $3.3201 USD to $3.325 USD; the price reported above reflects the weighted average sale price.